$42.16 -0.23 (-0.54%)
2/10/2012 4:00 PM

Cepheid (NASDAQ:CPHD)

CAPS Rating: 2 out of 5

A molecular diagnostics company that develops, manufactures, and markets fully-integrated systems for genetic analysis in the Clinical Molecular Diagnostic, Industrial and Biothreat markets.

Featured Broker Partners


Advertisement